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Whitening and Impaired Glucose 
Utilization of Brown Adipose Tissue 
in a Rat Model of Type 2 Diabetes 
Mellitus
Constantin Lapa1, Paula Arias-Loza2, Nobuyuki Hayakawa1, Hiroshi Wakabayashi1, Rudolf 
A. Werner1,3, Xinyu Chen1,4, Tetsuya Shinaji1, Ken Herrmann1, Theo Pelzer2 & Takahiro 
Higuchi1,4,5
Brown adipose tissue (BAT) is an attractive therapeutic target to combat diabetes and obesity due to 
its ability to increase glucose expenditure. In a genetic rat model (ZDF fa/fa) of type-2 diabetes and 
obesity, we aimed to investigate glucose utilization of BAT by 18F-FDG PET imaging. Male Zucker 
diabetic fatty (ZDF) and Male Zucker lean (ZL) control rats were studied at 13 weeks. Three weeks prior 
to imaging, ZDF rats were randomized into a no-restriction (ZDF-ND) and a mild calorie restriction 
(ZDF-CR) group. Dynamic 18F-FDG PET using a dedicated small animal PET system was performed under 
hyperinsulinemic-euglycemic clamp. 18F-FDG PET identified intense inter-scapular BAT glucose uptake 
in all ZL control rats, while no focally increased 18F-FDG uptake was detected in all ZDF-ND rats. Mild but 
significant improved BAT tracer uptake was identified after calorie restriction in diabetic rats (ZDF-CR). 
The weight of BAT tissue and fat deposits were significantly increased in ZDF-CR and ZDF-ND rats as 
compared to ZL controls, while UCP-1 and mitochondrial concentrations were significantly decreased. 
Whitening and severely impaired insulin-stimulated glucose uptake in BAT was confirmed in a rat model 
of type-2 diabetes. Additionally, calorie restriction partially restored the impaired BAT glucose uptake.
Obesity and its associated diseases, especially diabetes type 2, constitute one of the major public health concerns 
in most developed societies1. Taking only energetics into account, treatment of obesity by reducing caloric intake 
and increasing energy expenditure should be simple, however most patients fail to achieve or –more important- 
maintain weight loss goals through diet and exercise alone2. Therefore, pharmacologic and/or surgical treatment 
options to support patients in the fight against excessive body weight are increasingly sought for. It is currently 
known that body weight regulation goes beyond simple energetics and that other metabolic, behavioral, neuroen-
docrine, and autonomic responses play important roles in maintenance of the amount of fat reserves3.
Since its rediscovery in adult humans in the late 2000s, brown adipose tissue (BAT) has attracted a lot of atten-
tion as a potential target to combat obesity, and stimuli for its activation have been investigated in both animal 
models and humans4–14. As part of the mechanisms of adaptive thermogenesis, BAT enables the release of energy 
as heat instead of storage as energy molecules by dissociation of mitochondrial substrate oxidation from ATP 
production, a phenomenon mediated by uncoupling protein 1 (UCP-115), which is present in BAT, but not in 
white adipose tissue (WAT).
Most recently, experimental murine studies reported that diet-induced obesity resulted in impaired glucose 
tolerance, BAT functional hypoxia and subsequent structural “whitening” that eventually led to a functional shift 
from thermogenesis toward lipid storage16,17. The loss of functional BAT in obesity might be consistent with the 
lack of BAT response to both insulin and cold stimulation in obese adults18, whereas exposure to cold in young 
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subjects does stimulate BAT activity4. Preserved spontaneously activated BAT was also significantly higher in 
patients with low fasting plasma glucose levels (<93 mg/dl) as compared to patients with glucose levels higher 
than 103 mg/dl19. However, further knowledge about the relationship between type 2 diabetes mellitus and BAT 
is still very limited.
In this study, we aimed to investigate BAT glucose utilization in a well-established genetic rat model of type 2 
diabetes20 using 18F-FDG PET imaging under hyperinsulinemic-euglycemic clamping conditions. Rats were set 
under hyperinsulinemic-euglycemic conditions to stimulated BAT glucose consumption by high serum insulin 
concentrations during the imaging period21–23, furthermore the euglycemic status permitted to avoid interference 
of different plasma glucose concentrations between diabetic and control animals24.
Methods
Study approval. Animal studies were performed in agreement with the Guide for Care and Use of 
Laboratory Animals published by the US National Institutes of Health (NIH Publication No. 85-23, revised 1996) 
and in compliance with the German law on the protection of animals. Animal protocols were approved by the 
local Animal Care and Use Committee (Regierung von Unterfranken, Germany).
Small animal 18F-FDG-PET/CT imaging. Ten weeks old male Zucker diabetic fatty (ZDF; n = 11) were 
randomized into a no-restriction diet (ZDF-ND) group (n = 6) and a mild calorie restriction (ZDF-CR) group 
(n = 5), male Zucker lean (ZL) rats served as controls (n = 6) (Charles River, Wilmington, USA). All animal 
received water ad libitum. Diet intervention consisted in 3 weeks of: standard food ad libitum to ZL lean rats 
(daily food intake of 20.29 ± 1.97 g); Purina 5008 (protein 23%, fat 6.5%, carbohydrates 58.5%, fiber 4% and ash 
8%; as recommended by the supplier) ad libitum to ZDF-ND rats (daily food intake of 36.25 ± 5.8 g) and 20 g of 
Purina 5008 per day (the same weight of food ZL lean consumed per day) to ZDF-CR rats, respectively. At 13 
weeks of age, ZDF-ND rats (average weight, 356 ± 24 g), ZDF-CR rat (average weight, 354 ± 50 g) and controls 
(average weight, 290 ± 25 g) underwent 18F-FDG-PET at room temperature (23 °C) using a dedicated small ani-
mal PET scanner (Inveon; Siemens Medical Solutions, Erlangen, Germany).
General anesthesia was induced with isoflurane after fasting (>10 h). In order to maintain euglycemia as 
well as to stimulate glucose consumption of BAT, hyperinsulemic-euglycemic clamping24 was performed in each 
group (Fig. 1). Two catheters were placed into the tail veins for connection to the clamping system. Infusion of 
insulin (Insuman Rapid; Sanofi-Aventis, Paris, France) was started at a rate of 240mU/kg/min for 20 min followed 
by low-dose 12 mU/kg/min. In order to maintain euglycemia (blood glucose levels: 70–110 mg/l), varying rates of 
glucose (50.0% glucose solution) were added by checking blood glucose levels every 2 min. 18F-FDG (30-45MBq) 
was administrated intravenously at least 12 min after stable euglycemia had been established. Dynamic emission 
PET acquisition (35 min) was started just before tracer administration. A thirteen-minute transmission scan 
with a 57Co rotating source was also conducted prior to the emission scan. Data was reconstructed using ordered 
subset expectation maximization 2D algorithm with attenuation correction. Tracer uptake in BAT as percentage 
injected dose (%ID) was determined by assigning free-hand volumes of interest around foci at interscapular BAT 
area.
Ex-vivo tissue analysis. After completion of the PET scan, the animals were euthanized for ex-vivo BAT 
tissue analysis. Visual interscapular fat depots were resected and weighed.
For histological analysis, frozen specimens were sliced into 7-µm sections. Tissue sections were fixed (10-min 
acetone) and blocked with 10% bovine serum albumin. The tissue sections were subjected to staining using stand-
ard hematoxylin and eosin (H&E) staining protocol for histology. For immunofluorescence staining, the sec-
tions were incubated overnight for primary antibodies against UCP-1 (Abcam rabbit polyclonal, 1:500; Abcam, 
Cambridge, UK). Alexa Fluor 488 Donkey anti-rabbit antibody (Thermo Fisher Scientific, Waltham, MA, USA) 
was used as a secondary antibody. Mitochondria were stained by fluorescent staining (MitoGreen, PromoCell, 
concentration 200 nM; PromoCell, Heidelberg, Germany) and cellular lipids were stained by Oil red O staining 
(Abcam, Oil Red O kit)25 according to the manufacturer’s instructions. Microscopic images were obtained using a 
Keyence BZ-9000 microscope (Keyence Corp., Osaka, Japan). Analysis of images were performed on each sample 
(n = 4 rats per experimental group) at ×400 magnification with Image J software. Size of unilocular adipocytes 
Figure 1. Schematic diagram illustrating the 18F-FDG-PET imaging protocol. Dynamic 18F-FDG-PET scans 
were performed using hyperinsulinemic-euglycemic clamping which consisted of high-dose (240 mU/kg/
min) and subsequent low-dose (12 mU/kg/min) insulin plus glucose infusion (at variable rates) to obtain 
hyperinsulinemic-euglycemic conditions. iv = intravenous injection.
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were measured in H&E stained sections (6 fields per sample), and area of positively stained area was calculated 
for UCP-1 (8 per sample) and mitochondria staining (4 per sample).
Protein expression of interscapular fat depots was analyzed by Western blotting according to standard proto-
cols (Bio-rad, Trans-Blot Turbo System, Hercules, California, USA)26. The following antibodies were employed: 
UCP-1 (Abcam rabbit polyclonal, 1:500; Abcam) and acetyl-Co A Carboxylase (Cell Signaling, rabbit polyclonal, 
1:500, Cambridge, UK). Immunoreactive proteins were visualized by HRP-coupled antibodies (GE, Amersham, 
UK) and ECL. The ImageQuant software (Biometra, Göttingen, Germany) was used for densitometric analysis 
based on peak area; β-actin was employed as internal standard (Santa Cruz, mouse monoclonal, 1:200, Dallas, 
USA).
Statistical analysis. All data are presented as mean ± standard deviation. Statistical analysis was performed 
using GraphPad Prism Software. Statistical significance between the three groups was determined by one-way 
ANOVA followed by post hoc Tukey multiple comparison analysis. Differences between the means were consid-
ered statistically significant if p < 0.05.
Results
Imaging results. In hyperinsulinemic-euglycemic state, 18F-FDG PET identified intense inter-scapular tracer 
uptake consistent with BAT glucose utilization in all ZL control rats. BAT time activity curves demonstrated a 
rapid increase of tracer uptake during the initial 10 min after tracer injection followed by stable tracer retention 
until the end of the imaging session. In ZDF-CR rats, mild but focally increased 18F-FDG uptake was visible in all 
rats. In contrast, no focally increased 18F-FDG uptake could be detected in ZDF-ND rats at any time point (Fig. 2).
The 18F-FDG uptake (%ID) of interscapular BAT at 30 min after tracer injection was calculated as 
0.045 ± 0.006*,***, 0.28 ± 0.05** and 0.18 ± 0.07 in ZDF-ND rats, ZL control rats, and ZDF-CR rats, respec-
tively, demonstrating significant differences between each group (*p < 0.01 and **p < 0.001 vs ZDF-CR, and 
***p < 0.0001 vs ZDF-ND, Fig. 2B).
Histological analysis. At the time of dissection, interscapular BAT with its typical reddish brown colour 
was easily detected by direct visual inspection in ZL control rats, whereas interscapular fat depots in ZDF-CR and 
ZDF-ND rats presented as whitish brown (Fig. 3).
The weight of interscapular fat tissue was significantly higher in ZDF-CR and ZDF-ND rats as compared to ZL 
controls, and the size of adipocytes was significantly increased (Fig. 3). Microscopically, presence of brown adipo-
cytes with abundant expression of UCP-1 in mitochondria-rich cytoplasm could be confirmed in ZL control rats. 
In contrast, both ZDF-ND and ZDF-CR rats presented ubiquitous white adipose-like tissue, showing large uni-
locular lipid droplets with decreased positive staining signals for UCP-1 and mitochondria (Fig. 3). No significant 
differences were identified between ZDF-ND and –CR animals. UCP-1 data was confirmed by Western blot anal-
ysis that evidenced a significantly higher expression in ZL rats in comparison to ZDF-ND and CR rats (Fig. 4).
Figure 2. (A) Representative 18F-FDG PET images of ZL control (left), diabetic ZDF rat on a no-restriction 
diet (ZDF-ND, middle) and diabetic ZDF rat after three weeks of mild calorie restriction (ZDF-CR, right). 
Intense focal 18F-FDG uptake of BAT in the interscapular area was clearly depicted in the ZL control rat, while 
no apparent uptake was observed in the ZDF-ND rat (arrows). After calorie restriction (ZDF-CR), mild tracer 
uptake was identified in the interscapular area indicating improved BAT glucose utilization. (B) Average time-
activity curves of BAT in ZL control rats, with calorie restriction (ZDF-CR), and ZDF rats with no-restriction 
diet (ZDF-ND) (upper). Bar graph of FDG uptake (%ID) of BAT in ZL control, ZDF-ND, and ZDF-CR rats at 
the time point of 30 min after 18F-FDG injection (lower). BAT = brown adipose tissue. *p < 0.01, **p < 0.001 
and ***p < 0.0001.
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Figure 3. (A) Macroscopic, and microscopic view of H&E, immunofluorescence staining for UCP-1, 
fluorescence staining for mitochondria (MitoGreen), and Oil red O staining of interscapular fat depot in a 
ZL control, ZDF rat with no-restriction diet (ZDF-ND) and a ZDF rat with calorie restriction (ZDF-CR). 
In immunofluorescence staining for UCP-1 (green) and fluorescence staining for mitochondria (green) 
nuclei were stained with DAPI (blue) and cell membranes with wheat germ agglutinin (red). Visual analysis 
demonstrates a reduction in mitochondria and UCP-1 expression as well as an increase in fat cells in both 
ZDF-ND and ZDF-CR rats. (B) Bar graphs show weight of interscapular fat depot, size of adipocytes and 
percentage of positively stained area of UPC-1 and mitochondria staining in ZL control, ZDF-ND and ZDF-CR 
rats. *p < 0.05, **p < 0.01, ***p < 0.0001.
Figure 4. (A) Protein expression of the thermogenic protein UCP-1 in BAT was significantly higher in Zucker 
Lean (ZL, n = 6) control rats in comparison to diabetic rats with (ZDF-ND; n = 6) and without (ZDF-CR, n = 5) 
calorie restriction. (B) Protein expression of fatty acids synthesis protein acetyl-coenzyme A carboxylase (ACC) 
was significantly higher in BAT of ZDF-ND rats in comparison to ZL rats; ZDF-CR presented intermediate 
values that did not reach a significant difference to either ZL or ZDF-ND rats. β-Actin (BACT) was used as 
housekeeping control. *p < 0.05.
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Brown to white adipose tissue transition is accompanied by an increased synthesis and accumulation of intra-
cellular fatty acids. The key enzyme for the biosynthesis of fatty acid is acetyl-coenzyme A carboxylase (ACC) 
that catalyses the irreversible carboxylation of acetyl-CoA to produce malonyl-CoA. ZDF-ND rats presented 
significantly increased ACC levels in BAT in comparison to ZL rats. ZDF-CR BAT presented intermediate values 
that were not significantly different from ZL or ZDF-ND (Fig. 4).
Discussion
A number of previous studies have reported on impaired BAT glucose utilization in Zucker fa/fa rats27,28. However 
-to the best of our knowledge-, this is the first report directly providing PET in vivo data on BAT metabolism in 
a rat model of type 2 diabetes and obesity. In comparison to lean controls, obese diabetic ZDF rats had almost 
ubiquitously BAT functional loss as identified by FDG PET imaging. Morphologic transition from brown to white 
adipose like tissue was already evident upon visual inspection at the time of dissection and was further confirmed 
by histological work-up.
BAT activation has gained interest for its potential use in the treatment of obesity and diabetes type 2. Indeed, 
transplantation of BAT to mice has been shown to decrease body weight and improve glucose metabolism and 
insulin sensitivity23. Activation of BAT by cold exposure has been reported to lead to high consumption of glu-
cose and lipids far exceeding hepatic and skeletal muscle capacity, therefore increased glucose uptake by BAT is 
considered to reflect metabolic activity and thermogenesis3. In fact, lower FDG uptake and whitening of BAT in 
the ZDF rats was accompanied by decreased protein expression levels of UCP 1 and an increase in the fatty acids 
synthesis enzyme ACC. Whitening of BAT seems to be involved in the process of metabolic changes in type 2 
diabetes, leading to the so-called metabolic syndrome16,29.
In this study, all animals were analysed at an age of 13 weeks, in the mid-stage of diabetes-related morphologic 
and functional alterations20. Interestingly, calorie restriction 3 weeks prior to imaging evoked mild but significant 
BAT glucose utilization in ZDF rats, whereas UCP-1 expression was comparably low in ad libitum fed ZDF coun-
terparts. This finding might be explained by calorie restriction-induced changes in glucose uptake, potentially to 
already improved insulin sensitivity.
Furthermore, a trend towards reduction of ACC expression after calorie restriction could be detected and 
indicated reduction of fatty acids synthesis in the BAT.
Unfortunately, a more profound analysis of insulin resistance as well as serial imaging of the diabetic rats at 
earlier and later time points to further elucidate the temporal orchestration of BAT whitening was not performed. 
However, insight into the beginnings of BAT whitening could be of paramount importance to assess the optimal 
time point for both lifestyle and dietary modifications in order to prevent complete BAT loss.
This study has several further limitations. Besides calorie restriction, we did not perform any experiments 
aiming at potential further interventions to re-activate uptake of small reminiscent brown or brite adipocytes or 
to induce browning again30. In a recent human study, exposure to a cold environment, a well-known BAT stimulus 
in healthy men4,31, could also be demonstrated to increase BAT glucose uptake in obese subjects32. Interestingly, 
cold acclimation did not increase glucose uptake into subcutaneous and visceral white fat depots, implying that 
“browning” had not occurred. Future trials should focus on therapeutic strategies to achieve browning of WAT.
Increased glucose uptake in BAT in obese subjects following cold exposure might prevent induction of the 
obesity-associated insulin resistance due to ameliorated glucose homeostasis. Recent studies have hinted at the 
importance of brown fat for glucose disposal, insulin sensitivity and triglyceride metabolism23,33. Though the 
relationship of these metabolic pathways and BAT were beyond the scope of our study, we provide new insights 
into the relation between type 2 diabetes and obesity, brown adipocyte alteration and metabolism.
In brief, insulin-stimulated 18F-FDG uptake was significantly decreased in a rat model of type 2 diabetes and 
correlated with transition of BAT to white adipose-like tissue. Future research needs to explore the underlying 
mechanistic and biological implications, as well as therapeutic options for BAT induction as, ultimately, a novel 
approach to BAT-targeted treatment of obesity.
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